Linical Co., Ltd. (TYO:2183)

Japan flag Japan · Delayed Price · Currency is JPY
220.00
+1.00 (0.46%)
Jun 3, 2026, 3:30 PM JST
Market Cap4.97B -26.2%
Revenue (ttm)8.67B -17.0%
Net Income-3.33B
EPS-147.39
Shares Out 22.59M
PE Ration/a
Forward PEn/a
Dividend16.00 (7.31%)
Ex-Dividend DateMar 30, 2026
Volume31,800
Open219.00
Previous Close219.00
Day's Range214.00 - 220.00
52-Week Range214.00 - 363.00
Beta0.35
Analystsn/a
Price Targetn/a
Earnings DateMay 15, 2026

About Linical

Linical Co., Ltd., a global contract research organization provides full spectrum of drug development services to pharmaceutical companies worldwide. The company offers drug development consulting services, such as market analysis of products in development, regulatory affairs, and licensing support. It also provides clinical research and development, and contract medical affairs services, including front-end services comprising project management, monitoring, quality control, vendor management, auditing, and clinical research secretariats; and... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2005
Employees 598
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 2183
Full Company Profile

Financial Performance

In fiscal year 2026, Linical's revenue was 8.67 billion, a decrease of -16.98% compared to the previous year's 10.44 billion. Losses were -3.33 billion, 517.6% more than in 2025.

Financial Statements